BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23762304)

  • 1. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
    Kuroda T; Hirohashi Y; Torigoe T; Yasuda K; Takahashi A; Asanuma H; Morita R; Mariya T; Asano T; Mizuuchi M; Saito T; Sato N
    PLoS One; 2013; 8(6):e65158. PubMed ID: 23762304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
    Chen PX; Li QY; Yang Z
    Pathol Oncol Res; 2015 Sep; 21(4):1133-40. PubMed ID: 25971681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
    Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
    Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.
    Yasuda K; Torigoe T; Mariya T; Asano T; Kuroda T; Matsuzaki J; Ikeda K; Yamauchi M; Emori M; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
    Lab Invest; 2014 Dec; 94(12):1355-69. PubMed ID: 25329002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
    Inoue R; Hirohashi Y; Kitamura H; Nishida S; Murai A; Takaya A; Yamamoto E; Matsuki M; Tanaka T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Sato N; Masumori N; Torigoe T
    Oncotarget; 2017 Apr; 8(17):28826-28839. PubMed ID: 28418868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
    Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
    Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
    Ueda K; Ogasawara S; Akiba J; Nakayama M; Todoroki K; Ueda K; Sanada S; Suekane S; Noguchi M; Matsuoka K; Yano H
    PLoS One; 2013; 8(10):e75463. PubMed ID: 24116047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line.
    Wang Y; Jiang Y; Ikeda J; Tian T; Sato A; Ohtsu H; Morii E
    Cancer Med; 2014 Oct; 3(5):1126-35. PubMed ID: 25045085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors.
    Fischer AK; Pham DL; Bösmüller H; Lengerke C; Wagner P; Bachmann C; Beschorner C; Perner S; Kommoss S; Fend F; Staebler A
    Virchows Arch; 2019 Oct; 475(4):479-488. PubMed ID: 31451895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
    Shirosaki T; Kawai N; Ebihara Y; Murai A; Kubo T; Morita R; Murata K; Kanaseki T; Tsukahara T; Shichinohe T; Hirohashi Y; Hirano S; Torigoe T
    Anticancer Res; 2024 May; 44(5):1877-1883. PubMed ID: 38677758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
    Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
    J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer.
    Nunes M; Pacheco F; Coelho R; Leitão D; Ricardo S; David L
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
    Deng S; Yang X; Lassus H; Liang S; Kaur S; Ye Q; Li C; Wang LP; Roby KF; Orsulic S; Connolly DC; Zhang Y; Montone K; Bützow R; Coukos G; Zhang L
    PLoS One; 2010 Apr; 5(4):e10277. PubMed ID: 20422001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.
    Yasuda K; Torigoe T; Morita R; Kuroda T; Takahashi A; Matsuzaki J; Kochin V; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
    PLoS One; 2013; 8(8):e68187. PubMed ID: 23967051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
    Yu CH; Yu CC
    PLoS One; 2014; 9(1):e87129. PubMed ID: 24475244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study.
    Huang R; Li X; Holm R; Trope CG; Nesland JM; Suo Z
    BMC Cancer; 2015 Jul; 15():502. PubMed ID: 26148881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase 1: a specific cancer stem cell marker for human colorectal carcinoma.
    Zhou F; Mu YD; Liang J; Liu ZX; Zhou D; Ning WL; Li YZ; Ding D; Zhang JF
    Mol Med Rep; 2015 May; 11(5):3894-9. PubMed ID: 25585687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
    Ahmed N; Abubaker K; Findlay J; Quinn M
    J Cell Biochem; 2013 Jan; 114(1):21-34. PubMed ID: 22887554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
    Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.